Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery: a Prospective Randomized Trail in Comparison of Multiple-, Single- and Zero-dose.
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 450
- 试验地点
- 1
- 主要终点
- Postoperative SIRS
研究概览
简要总结
The purpose of this study is to compare the postoperative systemic inflammatory response syndrome (SIRS) rates undergoing retrograde intrarenal surgery (RIRS) after multiple-, single-, zero-dose of ceftriaxone prophylaxis in a prospective randomized trail.
The investigators will enroll 450 patients who are candidates for RIRS in the investigators study. By simple random sampling technique, patients will be assigned to three groups (multiple-, single-, zero-dose of ceftriaxone prophylaxis,respectively). In addition to the difference of usage of ciprofloxacin prophylaxis, the rest of the procedure is the same in all three groups.The end point of the study is the comparison of outcome of procedure including SIRS rate, stone free rate (SFR), operation time, length of stay,and hematuresis.
详细描述
PURPOSE:
To compare multiple-, single-, zero-dose antibiotic prophylaxis for retrograde intrarenal surgery (RIRS) and detect the ideal regimen to prevent systemic inflammatory response syndrome (SIRS).
METHODS:
An α error of 5% and a power of 80% were assumed to detect a 14.9% difference in rates of postoperative SIRS (5.1% for the antibiotic prophylaxis group and 20% for the control group) based on the historical data. According to sample size calculation formula for comparing rates between multiple independent samples, n=2λ/(2sin-1√Pmax-2sin-1√Pmin)2,the minimum sample sizes to detect statistically significant differences were estimated to be 86 patients for each of the study groups. To account for patients lost to follow-up and study withdrawals, this number was increased to 100.
After finishing the cases mentioned above, we find the difference in rates of postoperative SIRS in our center is 7.9% (1.2% for the antibiotic prophylaxis group and 9.1% for the control group). According to sample size calculation formula, the minimum sample sizes were estimated to be 124, additional 38 patients are required to be added to each group. For the accuracy and availability of the trial, we decided to enlarge the sample size.To account for patients lost to follow-up and study withdrawals, this number was increased to 150.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 70 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Positive preoperative urine culture
- •Pyruria (>10 white blood cells per high-power field)
- •Antibiotics treatment of UTI in the last 4 weeks
- •Immunocompromised
- •Diabetes mellitus
- •Allergy to quinolone
- •Existing ureteric stents
- •Turbid pelvic urine or purulent stone surface observed intraoperatively
- •Ureteral stricture, renal or urethral deformity
研究组 & 干预措施
Multiple-dose of ciprofloxacin prophylaxis
Multiple-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery and within 12 hours after surgery additionally
干预措施: Multiple-dose of Ciprofloxacin prophylaxis (Drug)
Single-dose of ciprofloxacin prophylaxis
Single-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery only
干预措施: Single-dose of Ciprofloxacin prophylaxis (Drug)
Zero-dose of ciprofloxacin prophylaxis
Zero-dose of ciprofloxacin prophylaxis with none intravenous ciprofloxacin either preoperatively or postoperatively
干预措施: Zero-dose of Ciprofloxacin prophylaxis (Drug)
结局指标
主要结局
Postoperative SIRS
时间窗: 4 weeks after RIRS
White blood count \< 4000 or \>12000 cells/mm3, heart rate \>90 beats per minute, temperature \<36°C or \>38°C, respiratory rate \> 20 breaths/min. Presence of two or more of these criteria was accepted as SIRS.
次要结局
- Postopeartive hospital stay(During the hospitalization)
- Operative time(intraoperatively)
- Stone free rate(4 weeks after RIRS)
- Hemoglobin drop(Within 24 hours after RIRS)
- Hematuresis(4 weeks after RIRS)
研究者
Guohua Zeng
Vice-president of The First Affiliated Hospital of Guangzhou Medical University
The First Affiliated Hospital of Guangzhou Medical University
